These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24631484)

  • 41. The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
    Ma J; Leung LS
    Psychopharmacology (Berl); 2007 May; 191(4):961-74. PubMed ID: 17219218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (
    Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels.
    Lorrain DS; Baccei CS; Correa LD; Bristow LJ
    Neuropharmacology; 2005 Jun; 48(7):927-35. PubMed ID: 15857619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
    Moldrich RX; Jeffrey M; Talebi A; Beart PM; Chapman AG; Meldrum BS
    Neuropharmacology; 2001 Jul; 41(1):8-18. PubMed ID: 11445181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals.
    Chin CL; Upadhyay J; Marek GJ; Baker SJ; Zhang M; Mezler M; Fox GB; Day M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):709-15. PubMed ID: 21172908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
    Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
    Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.
    Amitai N; Markou A
    Eur J Pharmacol; 2010 Aug; 639(1-3):67-80. PubMed ID: 20371228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.
    Liechti ME; Markou A
    Biochem Pharmacol; 2007 Oct; 74(8):1299-307. PubMed ID: 17601493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.
    Bond A; Jones NM; Hicks CA; Whiffin GM; Ward MA; O'Neill MF; Kingston AE; Monn JA; Ornstein PL; Schoepp DD; Lodge D; O'Neill MJ
    J Pharmacol Exp Ther; 2000 Sep; 294(3):800-9. PubMed ID: 10945827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268.
    Cartmell J; Monn JA; Schoepp DD
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):39-46. PubMed ID: 10651145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys.
    Adewale AS; Platt DM; Spealman RD
    J Pharmacol Exp Ther; 2006 Aug; 318(2):922-31. PubMed ID: 16675638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
    Hikichi H; Kaku A; Karasawa J; Chaki S
    J Pharmacol Sci; 2013; 122(1):10-6. PubMed ID: 23603933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344.
    Rorick-Kehn LM; Perkins EJ; Knitowski KM; Hart JC; Johnson BG; Schoepp DD; McKinzie DL
    J Pharmacol Exp Ther; 2006 Feb; 316(2):905-13. PubMed ID: 16223873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
    Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
    Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence.
    Aujla H; Martin-Fardon R; Weiss F
    Neuropsychopharmacology; 2008 Jul; 33(8):1818-26. PubMed ID: 17895914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats.
    Kawaura K; Karasawa J; Hikichi H
    Pharmacol Rep; 2016 Feb; 68(1):80-4. PubMed ID: 26721357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
    Chen HH; Stoker A; Markou A
    Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
    Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
    Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity.
    de la Fuente Revenga M; Ibi D; Cuddy T; Toneatti R; Kurita M; Ijaz MK; Miles MF; Wolstenholme JT; González-Maeso J
    Neuropsychopharmacology; 2019 Jan; 44(2):443-454. PubMed ID: 30038413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.